Konis Pharmaceutical

Solan, India Founded: 1995 • Age: 31 yrs
Manufactures high-quality pharmaceutical products, including tablets, capsules, syrups, suspensions, pellets, and injectables.

About Konis Pharmaceutical

Konis Pharmaceutical was a Healthcare company based in Solan (India) founded in 1995 by Koti Reddy, .Jayarami Reddy, and Sanjeeva Reddy. It manufactures high-quality pharmaceutical products, including tablets, capsules, syrups, suspensions, pellets, and injectables. It operates on a B2B model. The company has 20 employees. Its Indian entity Konis Pharmaceuticals Private Limited reported revenue of β‚Ή9.91 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Manufacturing and Prescription Medications. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.

Company details

Konis Pharmaceutical, based in Solan, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and prescription medications. Manufactures high-quality pharmaceutical products, including tablets, capsules, syrups, suspensions, pellets, and injectables. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

  • Headquarters Solan, India
  • Employees 20
  • Founders Koti Reddy, .Jayarami Reddy, Sanjeeva Reddy
  • Sectors
    Healthcare
  • Website konispharma.com
  • Legal Name Konis Pharmaceuticals Private Limited
  • Date of Incorporation 04 May, 2005
  • Jurisdiction & Distt Solan Hp, Himachal Pradesh, India
Key Metrics
  • Annual Revenue
    ₹9.91 Cr

    FY 2025 · +3% YoY

  • Net Profit
    ₹9.9 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹41 Lakh

    FY 2025 · 4% margin

  • Employee Count
    20

Board of directors of Konis Pharmaceuticals Private Limited (Konis Pharmaceutical)

Konis Pharmaceuticals Private Limited is the primary company behind Konis Pharmaceutical. The board of Konis Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Jhansi Rani Seelam, appointed in 2020. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jhansi Rani Seelam
DIN 08860624
Manager31 Jul 20206 yrs 2 moKonis Pharmaceuticals Private Limited
Rama Sanjeevareddy Seelam
DIN 08860625
Director07 Mar 20224 yrs 7 moKonis Pharmaceuticals Private Limited

People of Konis Pharmaceutical

3 people are tracked at Konis Pharmaceutical (3 in leadership); the tracked headcount is 20.

NameRoleGroup
Koti Reddy
Co-FounderLeadership
.Jayarami Reddy
Co-FounderLeadership
Sanjeeva Reddy
Co-FounderLeadership
Premium access

Complete people profiles for Konis Pharmaceutical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Konis Pharmaceutical

Figures of Konis Pharmaceuticals Private Limited, the primary company behind Konis Pharmaceutical, for FY 2025. Revenue was ₹9.91 Cr (+3% year on year). Net profit was ₹9.9 Lakh (1% margin). EBITDA was ₹41 Lakh (4% margin). Revenue has grown at a compounded annual rate of +10% over three years and +8% over five years.

  • ₹9.91 CrRevenue · FY 2025 · +3% YoY
  • ₹9.9 LakhNet profit · 1% margin
  • ₹41 LakhEBITDA · 4% margin
  • ₹20 LakhPaid-up capital
  • 20Employees (provident fund records)
  • +10%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Konis Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Konis Pharmaceutical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Konis Pharmaceutical

Konis Pharmaceutical has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
unither-pharma.com1993Paris, France––
Contract development and manufacturing organization for proprietary and generic drugs
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India––
Company offering a suite of R&D and manufacturing services for small molecules and generics
recipharm.com1995Jordbro, Sweden–1,083
Pharmaceutical development and manufacturing services are offered contractually.
corerxpharma.com2006Clearwater, United States$15M–
CDMO with a focus on early phase drug product development
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
windlas.com2001Gurugram, India$12.96M1,264
Biopharma regulatory affairs, quality control, and strategy services are provided.
medpharm.com1998Guildford, United Kingdom–108
Topical and inhaled drug delivery formulations are developed and manufactured.
Premium access

Detailed competitors of Konis Pharmaceutical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Konis Pharmaceutical (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Konis Pharmaceutical

Konis Pharmaceutical was founded in 1995.

Konis Pharmaceutical is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.

Konis Pharmaceutical has 20 employees.

The primary company behind Konis Pharmaceutical, Konis Pharmaceuticals Private Limited, reported revenue of β‚Ή9.91 Cr for FY 2025, up 3% year on year.

Konis Pharmaceutical, based in Solan, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and prescription medications. Manufactures high-quality pharmaceutical products, including tablets, capsules, syrups, suspensions, pellets, and injectables. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

Konis Pharmaceutical's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Konis Pharmaceutical operates through Konis Pharmaceuticals Private Limited.

The legal entities of Konis Pharmaceutical currently have 2 directors, including Jhansi Rani Seelam, Rama Sanjeevareddy Seelam.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available